- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
$9.29 high, DNA
Recs
Buyout soon. Over $12M worth of shares bought by one buyer in the past week.
http://biotech-buyout-rumors.blogspot.com/2012/07/over-12m-worth-of-gnom-shares-purchased.html
Recs
Like the Mayo Deal, Science, Price compared to ILMN
Recs
Recs
Mayo deal! Wow.
Recs
Recs
Reaching a buy opportunity
Recs
Recs
Sound model.
Recs
GNOM generates the highest quality genetic data out there at the moment. They are ramping up data production and their service model is innovative - it saves customers from having to buy expensive sequencers.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 10 of 10